Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 8,773-8,784 of 10,661

Drug study icon

CompletedNCT01922258

Flexible Dosing of Brexpiprazole for Mental health

This study is completed in the United States, in France, in Canada, .... It is testing flexible Dosing of Brexpiprazole for Mental health.

In United States

Mental healthDrugFrom 55 Years to 90 Years

Countries: United States, France, Canada, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Mental health

Drug study icon

CompletedNCT02202213

Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: Schizophrenia

Drug study icon

CompletedNCT02202226

Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: Schizophrenia

Drug study icon

CompletedNCT01397786

Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Canada, Colombia, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

TerminatedNCT03325894

Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 4 Years to 12 Years

Countries: United States
Sponsor: Shire
Condition: ADHD

Drug study icon

TerminatedNCT02968121

Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT02466386

Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 4 Years to 5 Years

Countries: United States
Sponsor: Shire
Condition: ADHD

Drug study icon

CompletedNCT01552772

Safety and Tolerability study of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole

This study is completed in the United States. It focuses on schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Schizophrenia

Behavioral study icon

CompletedNCT04183400

Safety Awareness For Empowerment (SAFE): An RCT With Young People Experiencing Homelessness

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 21 Years

Countries: United States
Sponsor: University of Denver
Condition: Addiction

Other study type icon

CompletedNCT02192554

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a study of Brexpiprazole or Placebo

This study is completed in the United States, in France, in Canada, .... It focuses on Mental health.

In United States

Mental healthObservational

Countries: United States, France, Canada, ...
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition: Mental health

Drug study icon

CompletedNCT06471686

Safety of Acamprosate in Treating Addiction in the Post Liver Transplant Populations

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: University of Southern California
Condition: Addiction

Drug study icon

TerminatedNCT02813447

Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Anxiety, DepressionDrugOver 40 Years

Countries: United States
Sponsor: Duke University
Condition: Anxiety, Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.